VistaGen Therapeutics stock forecast 2022 - 2025 - 2030 with analysis
VistaGen Therapeutics stock stood at $1.24000000953674 on 2022-03-31. According to latest technical analysis, VistaGen Therapeutics stock forecast for 2022 is $1.0, forecast for 2023 is $0.85, forecast for 2024 is $0.71, forecast for 2025 is $0.54, forecast for 2026 is $0.64, forecast for 2027 is $0.52, forecast for 2028 is $0.79, forecast for 2029 is $1.05, forecast for 2030 is $0.96, and forecast for 2031 is $0.94.
| year | Average | Low | High | Change from 2022-03-31 | Avg. Change from previous year |
|---|---|---|---|---|---|
| 2022 | $1.0 | $0.95 | $1.15 | -19.51% | - |
| 2023 | $0.85 | $0.72 | $0.97 | -31.49% | -15.00% |
| 2024 | $0.71 | $0.69 | $0.71 | -43.12% | -16.47% |
| 2025 | $0.54 | $0.49 | $0.66 | -56.58% | -23.94% |
| 2026 | $0.64 | $0.59 | $0.66 | -48.38% | 18.52% |
| 2027 | $0.52 | $0.41 | $0.62 | -58.16% | -18.75% |
| 2028 | $0.79 | $0.63 | $1.0 | -36.05% | 51.92% |
| 2029 | $1.05 | $1.01 | $1.09 | -15.17% | 32.91% |
| 2030 | $0.96 | $0.83 | $1.09 | -22.89% | -8.57% |
| 2031 | $0.94 | $0.9 | $1.02 | -23.92% | -2.08% |
| 2032 | $0.88 | $0.84 | $0.92 | -29.02% | -6.38% |
VistaGen Therapeutics stock forecast for next 5 days
| Date | Price Target | Change from previous day |
|---|---|---|
| 2022-04-01 | $1.36 | 9.63% |
| 2022-04-04 | $1.35 | -0.85% |
| 2022-04-05 | $1.30 | -3.66% |
| 2022-04-06 | $1.28 | -1.23% |
| 2022-04-07 | $1.28 | -0.39% |
Graph for Long term VTGN stock forecast
VistaGen Therapeutics stock forecast 2022
VistaGen Therapeutics stock price for 2022 May. will be $1.15. The highest price in 2022 will be $1.15, the lowest price will be $0.95, and the average price will be $1.0, which is -19.51% from the close price of 2022-03-31.
| Date | Price Target | Change From Previous Month | Change from 2022-03-31 | Change from 2022 May. |
|---|---|---|---|---|
| 2022 May. | $1.15 | -6.86% | -6.86% | 0% |
| 2022 Jun. | $1.04 | -10.20% | -16.36% | -10.20% |
| 2022 Jul. | $.99 | -4.49% | -20.11% | -14.23% |
| 2022 Aug. | $.97 | -1.95% | -21.67% | -15.90% |
| 2022 Sep. | $.95 | -2.32% | -23.49% | -17.85% |
| 2022 Oct. | $.95 | -0.14% | -23.59% | -17.96% |
| 2022 Nov. | $.97 | 2.20% | -21.91% | -16.16% |
| 2022 Dec. | $.97 | -0.25% | -22.10% | -16.36% |
VistaGen Therapeutics stock forecast 2023
In 2023, VistaGen Therapeutics stock price will start from .97, and it will end at .72. It is about -42.14% from today. Also, VistaGen Therapeutics stock is expected to drop -25.81% during 2023. The highest price in 2023 will be $0.97, the lowest price will be $0.72, and the average price will be $0.85, which is -31.49% from the close price of 2022-03-31.
| Date | Price Target | Change From Previous Month | Change from 2022-03-31 | Change from 2023 Jan. |
|---|---|---|---|---|
| 2023 Jan. | $.97 | 0.12% | -22.01% | 0.00% |
| 2023 Feb. | $.96 | -1.21% | -22.95% | -1.21% |
| 2023 Mar. | $.93 | -2.25% | -24.69% | -3.44% |
| 2023 Apr. | $.91 | -2.21% | -26.35% | -5.57% |
| 2023 May. | $.91 | -0.65% | -26.83% | -6.19% |
| 2023 Jun. | $.89 | -1.82% | -28.17% | -7.90% |
| 2023 Jul. | $.85 | -4.37% | -31.31% | -11.93% |
| 2023 Aug. | $.81 | -4.92% | -34.69% | -16.26% |
| 2023 Sep. | $.77 | -4.67% | -37.74% | -20.17% |
| 2023 Oct. | $.75 | -3.21% | -39.74% | -22.73% |
| 2023 Nov. | $.73 | -2.47% | -41.23% | -24.64% |
| 2023 Dec. | $.72 | -1.55% | -42.14% | -25.81% |
VistaGen Therapeutics stock forecast 2024
In 2024, VistaGen Therapeutics stock price is expected to move from .71, and it will finish the year at .69. It is about -44.01% from today. Also, VistaGen Therapeutics stock price is expected to decrease -2.21% during 2024. The highest price in 2024 will be $0.71, the lowest price will be $0.69, and the average price will be $0.71, which is -43.12% from the close price of 2022-03-31.
| Date | Price Target | Change From Previous Month | Change from 2022-03-31 | Change from 2024 Jan. |
|---|---|---|---|---|
| 2024 Jan. | $.71 | -1.05% | -42.74% | 0.00% |
| 2024 Feb. | $.71 | -0.60% | -43.09% | -0.60% |
| 2024 Mar. | $.70 | -0.12% | -43.16% | -0.72% |
| 2024 Apr. | $.71 | 0.06% | -43.12% | -0.66% |
| 2024 May. | $.71 | -0.01% | -43.13% | -0.67% |
| 2024 Jun. | $.71 | 0.02% | -43.12% | -0.65% |
| 2024 Jul. | $.71 | 0.18% | -43.01% | -0.47% |
| 2024 Aug. | $.71 | 0.23% | -42.89% | -0.25% |
| 2024 Sep. | $.71 | -0.01% | -42.89% | -0.26% |
| 2024 Oct. | $.71 | -0.12% | -42.96% | -0.38% |
| 2024 Nov. | $.70 | -0.65% | -43.33% | -1.03% |
| 2024 Dec. | $.69 | -1.20% | -44.01% | -2.21% |
VistaGen Therapeutics stock forecast 2025
In 2025, VistaGen Therapeutics stock price is expected to move from .66, and it will finish the year at .57. It is about -54.13% from today. Furthermore, our analysis for VistaGen Therapeutics stock prediction says that it is expected to go down -14.32% during 2025. The highest price in 2025 will be $0.66 and the lowest price will be $0.49. The average VTGN stock price during 2025 will be $0.54, which is -56.58% from the close price of 2022-03-31. Also, the expected average VistaGen Therapeutics share price for 2025 is -23.94% lower than the average for 2024
| Date | Price Target | Change From Previous Month | Change from 2022-03-31 | Change from 2025 Jan. |
|---|---|---|---|---|
| 2025 Jan. | $.66 | -4.37% | -46.46% | 0.00% |
| 2025 Feb. | $.58 | -13.37% | -53.62% | -13.37% |
| 2025 Mar. | $.54 | -5.67% | -56.25% | -18.29% |
| 2025 Apr. | $.52 | -4.20% | -58.09% | -21.72% |
| 2025 May. | $.51 | -2.02% | -58.93% | -23.30% |
| 2025 Jun. | $.50 | -2.17% | -59.83% | -24.96% |
| 2025 Jul. | $.49 | -0.70% | -60.11% | -25.49% |
| 2025 Aug. | $.50 | 0.97% | -59.72% | -24.77% |
| 2025 Sep. | $.51 | 2.62% | -58.66% | -22.79% |
| 2025 Oct. | $.53 | 3.27% | -57.31% | -20.27% |
| 2025 Nov. | $.55 | 3.54% | -55.80% | -17.45% |
| 2025 Dec. | $.57 | 3.79% | -54.13% | -14.32% |
VistaGen Therapeutics stock forecast 2026
In 2026, VistaGen Therapeutics stock price is expected to move from .59, and it will finish the year at .65. It is about -47.86% from today. Also, VistaGen Therapeutics stock price is expected to increase 8.69% during 2026. The highest price in 2026 will be $0.66, the lowest price will be $0.59, and the average price will be $0.64, which is -48.38% from the close price of 2022-03-31.
| Date | Price Target | Change From Previous Month | Change from 2022-03-31 | Change from 2026 Jan. |
|---|---|---|---|---|
| 2026 Jan. | $.59 | 4.58% | -52.03% | 0.00% |
| 2026 Feb. | $.62 | 4.67% | -49.79% | 4.67% |
| 2026 Mar. | $.64 | 2.54% | -48.52% | 7.33% |
| 2026 Apr. | $.64 | 0.52% | -48.25% | 7.89% |
| 2026 May. | $.64 | -0.11% | -48.30% | 7.77% |
| 2026 Jun. | $.64 | -0.08% | -48.35% | 7.68% |
| 2026 Jul. | $.64 | 0.19% | -48.25% | 7.88% |
| 2026 Aug. | $.64 | 0.47% | -48.00% | 8.39% |
| 2026 Sep. | $.65 | 1.07% | -47.45% | 9.55% |
| 2026 Oct. | $.66 | 1.12% | -46.86% | 10.77% |
| 2026 Nov. | $.66 | -0.10% | -46.92% | 10.66% |
| 2026 Dec. | $.65 | -1.78% | -47.86% | 8.69% |
VistaGen Therapeutics stock forecast 2027
In 2027, VistaGen Therapeutics stock price is expected to move from .62, and it will finish the year at .61. It is about -50.75% from today. Also, VistaGen Therapeutics stock price is expected to decrease -1.77% during 2027. The highest price in 2027 will be $0.62, the lowest price will be $0.41, and the average price will be $0.52, which is -58.16% from the close price of 2022-03-31.
| Date | Price Target | Change From Previous Month | Change from 2022-03-31 | Change from 2027 Jan. |
|---|---|---|---|---|
| 2027 Jan. | $.62 | -3.83% | -49.86% | 0.00% |
| 2027 Feb. | $.58 | -6.64% | -53.19% | -6.64% |
| 2027 Mar. | $.52 | -9.60% | -57.68% | -15.60% |
| 2027 Apr. | $.47 | -11.01% | -62.34% | -24.90% |
| 2027 May. | $.43 | -8.93% | -65.70% | -31.60% |
| 2027 Jun. | $.41 | -3.17% | -66.79% | -33.77% |
| 2027 Jul. | $.43 | 5.01% | -65.13% | -30.45% |
| 2027 Aug. | $.48 | 10.04% | -61.63% | -23.47% |
| 2027 Sep. | $.52 | 9.90% | -57.83% | -15.89% |
| 2027 Oct. | $.56 | 7.52% | -54.65% | -9.56% |
| 2027 Nov. | $.59 | 5.02% | -52.38% | -5.03% |
| 2027 Dec. | $.61 | 3.42% | -50.75% | -1.77% |
VistaGen Therapeutics stock forecast 2028
In 2028, VistaGen Therapeutics stock price is expected to move from .63, and it will finish the year at 1.00. It is about -18.95% from today. Also, VistaGen Therapeutics stock price is expected to increase 60.31% during 2028. The highest price in 2028 will be $1.0, the lowest price will be $0.63, and the average price will be $0.79, which is -36.05% from the close price of 2022-03-31.
| Date | Price Target | Change From Previous Month | Change from 2022-03-31 | Change from 2028 Jan. |
|---|---|---|---|---|
| 2028 Jan. | $.63 | 2.64% | -49.44% | 0.00% |
| 2028 Feb. | $.64 | 1.74% | -48.57% | 1.74% |
| 2028 Mar. | $.65 | 1.35% | -47.88% | 3.11% |
| 2028 Apr. | $.66 | 2.34% | -46.66% | 5.51% |
| 2028 May. | $.69 | 4.80% | -44.10% | 10.58% |
| 2028 Jun. | $.74 | 6.36% | -40.54% | 17.61% |
| 2028 Jul. | $.79 | 7.50% | -36.08% | 26.43% |
| 2028 Aug. | $.85 | 7.27% | -31.44% | 35.62% |
| 2028 Sep. | $.90 | 6.24% | -27.16% | 44.08% |
| 2028 Oct. | $.97 | 7.05% | -22.02% | 54.24% |
| 2028 Nov. | $.99 | 2.85% | -19.80% | 58.64% |
| 2028 Dec. | $1.00 | 1.05% | -18.95% | 60.31% |
VistaGen Therapeutics stock forecast 2029
In 2029, VistaGen Therapeutics stock price is expected to move from 1.01, and it will finish the year at 1.09. It is about -12.22% from today. Also, VistaGen Therapeutics stock price is expected to increase 7.68% during 2029. The highest price in 2029 will be $1.09, the lowest price will be $1.01, and the average price will be $1.05, which is -15.17% from the close price of 2022-03-31.
| Date | Price Target | Change From Previous Month | Change from 2022-03-31 | Change from 2029 Jan. |
|---|---|---|---|---|
| 2029 Jan. | $1.01 | 0.59% | -18.47% | 0.00% |
| 2029 Feb. | $1.02 | 0.67% | -17.92% | 0.67% |
| 2029 Mar. | $1.03 | 0.85% | -17.23% | 1.53% |
| 2029 Apr. | $1.04 | 0.95% | -16.44% | 2.50% |
| 2029 May. | $1.05 | 0.91% | -15.68% | 3.43% |
| 2029 Jun. | $1.05 | 0.65% | -15.13% | 4.10% |
| 2029 Jul. | $1.06 | 0.56% | -14.65% | 4.69% |
| 2029 Aug. | $1.07 | 0.66% | -14.09% | 5.38% |
| 2029 Sep. | $1.07 | 0.53% | -13.64% | 5.93% |
| 2029 Oct. | $1.07 | 0.16% | -13.50% | 6.10% |
| 2029 Nov. | $1.08 | 0.53% | -13.05% | 6.66% |
| 2029 Dec. | $1.09 | 0.95% | -12.22% | 7.68% |
VistaGen Therapeutics stock forecast 2030
In 2030, VistaGen Therapeutics stock price is expected to move from 1.09, and it will finish the year at 1.02. It is about -17.91% from today. Also, VistaGen Therapeutics stock price is expected to decrease -6.57% during 2030. The highest price in 2030 will be $1.09, the lowest price will be $0.83, and the average price will be $0.96, which is -22.89% from the close price of 2022-03-31.
| Date | Price Target | Change From Previous Month | Change from 2022-03-31 | Change from 2030 Jan. |
|---|---|---|---|---|
| 2030 Jan. | $1.09 | 0.08% | -12.14% | 0.00% |
| 2030 Feb. | $1.07 | -2.18% | -14.06% | -2.18% |
| 2030 Mar. | $1.01 | -5.44% | -18.73% | -7.49% |
| 2030 Apr. | $.93 | -7.89% | -25.14% | -14.79% |
| 2030 May. | $.86 | -7.37% | -30.66% | -21.07% |
| 2030 Jun. | $.83 | -3.19% | -32.87% | -23.59% |
| 2030 Jul. | $.85 | 2.42% | -31.24% | -21.74% |
| 2030 Aug. | $.90 | 5.81% | -27.25% | -17.20% |
| 2030 Sep. | $.94 | 4.63% | -23.89% | -13.36% |
| 2030 Oct. | $.97 | 3.11% | -21.52% | -10.67% |
| 2030 Nov. | $1.00 | 2.78% | -19.34% | -8.19% |
| 2030 Dec. | $1.02 | 1.76% | -17.91% | -6.57% |
VistaGen Therapeutics stock forecast 2031
In 2031, VistaGen Therapeutics stock price is expected to move from 1.02, and it will finish the year at .94. It is about -24.54% from today. Also, VistaGen Therapeutics stock price is expected to decrease -8.33% during 2031. The highest price in 2031 will be $1.02, the lowest price will be $0.9, and the average price will be $0.94, which is -23.92% from the close price of 2022-03-31.
| Date | Price Target | Change From Previous Month | Change from 2022-03-31 | Change from 2031 Jan. |
|---|---|---|---|---|
| 2031 Jan. | $1.02 | 0.28% | -17.69% | 0.00% |
| 2031 Feb. | $1.01 | -1.27% | -18.73% | -1.27% |
| 2031 Mar. | $.98 | -3.08% | -21.24% | -4.31% |
| 2031 Apr. | $.94 | -3.93% | -24.33% | -8.08% |
| 2031 May. | $.91 | -2.54% | -26.26% | -10.41% |
| 2031 Jun. | $.91 | -1.01% | -27.00% | -11.32% |
| 2031 Jul. | $.90 | -0.03% | -27.02% | -11.34% |
| 2031 Aug. | $.91 | 0.89% | -26.37% | -10.56% |
| 2031 Sep. | $.93 | 1.44% | -25.31% | -9.27% |
| 2031 Oct. | $.94 | 1.19% | -24.42% | -8.19% |
| 2031 Nov. | $.94 | 0.41% | -24.11% | -7.81% |
| 2031 Dec. | $.94 | -0.57% | -24.54% | -8.33% |
VistaGen Therapeutics stock forecast 2032
In 2032, VistaGen Therapeutics stock price is expected to move from .92. The highest price in 2032 will be $0.92, the lowest price will be $0.84, and the average price will be $0.88, which is -29.02% from the close price of 2022-03-31.
| Date | Price Target | Change From Previous Month | Change from 2022-03-31 | Change from 2032 Jan. |
|---|---|---|---|---|
| 2032 Jan. | $.92 | -1.60% | -25.75% | 0.00% |
| 2032 Feb. | $.90 | -2.56% | -27.65% | -2.56% |
| 2032 Mar. | $.87 | -3.31% | -30.05% | -5.79% |
| 2032 Apr. | $.84 | -3.71% | -32.65% | -9.29% |
Historical price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| 2022-03-14 | $1.14 | $1.20 | $1.12 | $1.24 |
| 2022-03-15 | $1.14 | $1.15 | $1.06 | $1.16 |
| 2022-03-16 | $1.23 | $1.17 | $1.11 | $1.23 |
| 2022-03-17 | $1.27 | $1.21 | $1.18 | $1.28 |
| 2022-03-18 | $1.23 | $1.25 | $1.21 | $1.34 |
| 2022-03-21 | $1.18 | $1.24 | $1.18 | $1.28 |
| 2022-03-22 | $1.16 | $1.18 | $1.15 | $1.21 |
| 2022-03-23 | $1.21 | $1.17 | $1.16 | $1.26 |
| 2022-03-24 | $1.25 | $1.24 | $1.22 | $1.29 |
| 2022-03-25 | $1.18 | $1.26 | $1.18 | $1.27 |
| 2022-03-28 | $1.16 | $1.20 | $1.13 | $1.21 |
| 2022-03-29 | $1.18 | $1.17 | $1.17 | $1.21 |
| 2022-03-30 | $1.22 | $1.21 | $1.17 | $1.26 |
| 2022-03-31 | $1.24 | $1.22 | $1.21 | $1.24 |